4DMedical Limited (ASX: 4DX) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
4DMedical Limited Chart and Price Data
Fundamentals Data provided by Morningstar.
Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
4DMedical Limited (ASX: 4DX)
Latest News
Broker Notes
This exciting small cap ASX share could rocket almost 40%
Share Gainers
Why 4DMedical, Genesis Minerals, Harvey Norman, and RPMGlobal shares are charging higher
Healthcare Shares
Guess which ASX healthcare stock is rocketing 42% on Pro Medicus investment
Share Gainers
Why 4DMedical, Gold Road, Syrah, and Tyro shares are racing higher today
Healthcare Shares
Why is this ASX All Ords stock surging 14% today?
Share Gainers
Guess which ASX All Ords stock just rocketed 28% on a new commercial contract!
Healthcare Shares
3 ASX healthcare stocks soaring on positive company updates
Share Gainers
Why 4DMedical, Boss Energy, Syrah, and Vulcan shares are charging higher today
Small Cap Shares
Guess which small cap ASX stock is jumping 12% despite the market selloff
Healthcare Shares
ASX All Ords stock rockets 18% on FDA clearance
Share Gainers
Why 4DMedical, Brainchip, Meridian, and SCEE shares are rising today
Healthcare Shares
2 ASX healthcare small-cap shares to buy now: brokers
Frequently Asked Questions
-
No, 4DMedical does not pay dividends at this time.
-
4DMedical listed on the ASX on 7 August 2020.
4DX ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About 4DMedical Limited
4DMedical Ltd (ASX: 4DX) is a medical technology company working in the field of respiratory imaging and ventilation analysis in the treatment of lung and respiratory diseases.
The company's non-invasive lung imaging technology emanates from research work undertaken at Monash University. It is the first FDA-cleared respiratory imaging solution that uses mathematical models and algorithms to convert sequences of X-ray images into four-dimensional quantitative data.
The technology uses existing imaging systems and allows X-ray images to be taken simultaneously from various angles. Using image-processing methods adapted from aerospace engineering, the motion of lung tissue can be measured. This allows ventilation to be calculated at each stage of the breath and at every location within the lung. These measurements are then visualized as a coloured heat map to help medical professionals accurately identify ventilation deficits.
The 4DMedical technology is patented in key jurisdictions, including the US and Australia. The company is aiming to secure a slice of the global lung imaging market. The US market alone was valued at more than $US30 billion in normal pre-COVID diagnostic conditions.
